Additional concerns include… -The authors report that they looked at "medications prescribed at discharge" but what is meant by this is not clear. Does this mean that only medications where the clinician wrote a prescription were counted? For example, if the patient had an adequate supply of a chronic medication at home and so a prescription wasn't written, was this medication not captured? -It is not clear to me why transiently prescribed medications were not included. This is a limitation of the study and may have significantly swayed results. For example, the number NSAIDs added or prescribed at discharge was 0, likely because those recommended were recommended for short term use. However, closer examination of the Beers criteria reveals that not all NSAIDs are created equal-indomethacin for example should not be a first choice for an NSAID if one is needed. Additional examples include, short term use of metoclopramide or scopolamine-there are alternative agents for nausea that should be considered and short term use of benzodiazepines. -Proton pump inhibitors were among the most common PIMs reported, but per the Beers list the inappropriateness of this medication is conditional. Use over 8 weeks is inappropriate-was the author able to determine how long someone had been on this medication prior to admission or whether they had met the other qualifications (i.e.-failure of drug discontinuation in the outpatient setting) -Minor points -Line 139 -Says "electronic medical," I believe the word record should be added -PPI→ time limited, how did they know it was appropriate or not? -Line 214 -"did not changed or increased" should be "did not change or increase" -Line 238-The authors report that length of stay in Japan is longer than in other countries but that in other countries longer length of stay is associated with higher PIM risk. This is an inappropriate justification as countries where shorter length of stay is the norm and longer lengths of stay may represent more complicated cases where the options for treatment are limited and thus the clinicians ultimately resort to a PIM after several other failed trials of other medications.
- Table S1 -"Current drinker"-what does this mean? How is this defined? -Line 126 -What does "characteristics of PIMs" mean? new findings. The paper published in 2011 by Sakuma et al. already showed the detailed epidemiology of potentially inappropriate medication use defined by Beers Criteria in elderly inpatients in Japanese acute care hospitals, which was a prospective cohort study including 2155 elderly inpatients. The following are comments according to Review checklist above: #7. Though the continuous variables are all presented as means and SD, some variables may be appropriate to be presented as medians with interquartile range. Generally, the distribution of the number of medications tends to be skewed. #8. Please refer the comment above. #11. In discussion, the author did not show any application or clinical implications of findings from this study. Therefore, I can not understand the value or impact of findings from this study on healthcare of Japan or worldwide. In addition, the author did not mention about the reason of PIMs reduction. More discussion about the interpretation of the PIMs reduction could be interesting. #12. The author listed several limitations, however, potential bias caused by those limitations are not mentioned. #15. May need some language corrections before being published. After reviewing these all comment consider this manuscript for publications.
REVIEWER

VERSION 1 -AUTHOR RESPONSE
Response to Reviewer #1
Comment 1: The author reports that this is the first report of PIM prevalence in hospitalized older adults in Japan. A cursory literature review reveals at least 2 studies looking at PIM use in Japanese older adults-in long term care and in health insurance claims (including inpatient stays), one of which is cited in the text (ref #27 (2):209-14). However, they excluded patients who were taking no medications at admission (the number of patients with no medications at admission or patients who died during hospitalization were not reported in the article), and they did not evaluate the PIM prevalence at discharge. Thus, I think that the present study is the first to investigate the PIM prevalence at admission and discharge in hospitalized elderly patients with acute medical illness in Japan. Moreover, given that there are a few studies regarding the epidemiology of PIM in elderly patients in acute care settings in Japan, I think that results of the present study are important.
Comment 2: Overall, the authors use clear language, have appropriately addressed the research question they set out, but the results are of limited significance. They are largely confounded due to use of bivariate analyses, I have significant concerns about the application of the Beers criteria (see below), and the single center design makes it difficult to understand how generalizable the results are. Response: Thank you for your comments. The single-center design is one of limitations of the present study, as you pointed out. However, most past studies investigating the PIM prevalence at admission and discharge also had single-center designs, although the primary aims of some of the studies were different ( Comment 3: The authors report that they looked at "medications prescribed at discharge" but what is meant by this is not clear. Does this mean that only medications where the clinician wrote a prescription were counted? For example, if the patient had an adequate supply of a chronic medication at home and so a prescription wasn't written, was this medication not captured? Response: I apologize for the confusion. "Medications prescribed at discharge" refers to all regular medications used at discharge. Therefore, chronic medications for which the patient had an adequate supply at home were included. This information has been added to the Method section of the revised manuscript (Page 7, Line 113-114).
Comment 4: It is not clear to me why transiently prescribed medications were not included. This is a limitation of the study and may have significantly swayed results. For example, the number NSAIDs added or prescribed at discharge was 0, likely because those recommended were recommended for short term use. However, closer examination of the Beers criteria reveals that not all NSAIDs are created equal-indomethacin for example should not be a first choice for an NSAID if one is needed. Additional examples include, short term use of metoclopramide or scopolamine-there are alternative agents for nausea that should be considered and short term use of benzodiazepines.
Response: Thank you for your comments. Transiently prescribed medications were not included because one of aims of this study was to determine the temporal change in PIM prevalence from admission to discharge in terms of regularly prescribed medications. Furthermore, given that misdiagnosis is common in elderly patients in primary care settings (JAMA Intern Med 2013; 173(6):418-25; Int J Gen Med 2016; 9:137-46) and that upper respiratory tract infection is often the trigger of heart failure, the inclusion of medications indicated for apparent transient disease overestimates the temporal reduction of PIM prevalence from admission to discharge. Therefore, transiently prescribed medications were excluded. At my hospital, most internal medicine physicians make an effort to avoid and reduce PIMs and polypharmacy for hospitalized elderly patients (BMC Geriatrics 2017; 17:288) . Therefore, internal medicine physicians rarely prescribe NSAIDs and antipsychotics for hospitalized elderly patients, even for the short term. Furthermore, NSAIDs and antipsychotics prescribed at admission are often stopped after admission, as Table 4 shows. Scopolamine is also rarely used for hospitalized elderly patients with the eight acute medical illnesses included in the present study. In addition, benzodiazepines and hypnotics are also avoided or stopped as soon as possible after admission at my hospital, although it is often difficult to reduce the use of benzodiazepines and hypnotics. This information has been added to the Method and Discussion sections of the revised manuscript (Page 7, Line 117-124; Page 15, Line 250-255).
Comment 5: Proton pump inhibitors were among the most common PIMs reported, but per the Beers list the inappropriateness of this medication is conditional. Use over 8 weeks is inappropriate-was the author able to determine how long someone had been on this medication prior to admission or whether they had met the other qualifications (i.e.-failure of drug discontinuation in the outpatient setting) Response: I apologize for this oversight. Given that the potentially inappropriate use of proton pump inhibitors (PPIs) defined by the 2015 Beers criteria targeted only the long-term use of PPIs (> 8 weeks), most PPIs that were newly started during hospitalization, regardless of their appropriateness, were not judged to be PIMs at discharge because the duration of hospital stay was often ≤ 8 weeks. Moreover, the Beers criteria's definition of high-risk patients for whom prophylactic use of PPIs is appropriate was ambiguous. Therefore, based on a previous study (J Am Geriatr . Thus, it is unclear how some PPIs that were newly started during hospitalization were judged to be PIM in these two recent studies. To evaluate the temporal change in the PIM prevalence from admission to discharge, I think an alternative definition of potentially inappropriate use of PPIs in hospitalized elderly patients is needed.
Comment 6: Line 139 -Says "electronic medical," I believe the word record should be added Response: I apologize for this point. I have modified this phrase in the revised manuscript (Page 9, Line 161).
Comment 7: PPI→ time limited, how did they know it was appropriate or not? Response: I apologize for this point. As I mentioned above, PPI therapy was deemed potentially inappropriate if the patients had none of the following indications: (1) peptic ulcer disease; (2) GERD with or without esophagitis; (3) Helicobacter pylori eradication therapy; (4) pathological hypersecretory, conditions such as Zollinger-Ellison syndrome; (5) use of NSAIDs; (6) use of antiplatelet therapy and at least one risk factor (history of peptic ulcer or concomitant use of anticoagulants, corticosteroids or glucocorticoids).
Comment 8: Line 214 -"did not changed or increased" should be "did not change or increase" Response: I apologize for this point. This sentence has been modified in the revised manuscript (Page 14, Line 249).
Comment 9: Line 238-The authors report that length of stay in Japan is longer than in other countries but that in other countries longer length of stay is associated with higher PIM risk. This is an inappropriate justification as countries where shorter length of stay is the norm and longer lengths of stay may represent more complicated cases where the options for treatment are limited and thus the clinicians ultimately resort to a PIM after several other failed trials of other medications. Response: Thank you for your comments. I agree. This statement has been modified in the Limitations section of the revised manuscript (Page 16, Line 279-281).
Comment 10: Table S1 -"Current drinker"-what does this mean? How is this defined? Response: I apologize for this point. "Current drinker" was defined as a patient who drank any alcoholic beverage every day, regardless of volume. This information has been added to Table S1 in the revised manuscript. Comment 2: Page 6, Lines 90-91 (they were the most common causes of hospitalization due to acute medical illness in elderly patients in this hospital) -This is a general statement, is there a reference for this assertion? Response: I apologize for the confusion. There is no reference for this statement. Therefore, this statement has been removed from the revised manuscript.
Comment 3: Page 10, Lines 155-160 -Can the inclusion and exclusion of patients be displayed schematically? This will make your point easily visible. Response: Thank you for your comment. According to your suggestion, the inclusion and exclusion of patients are shown schematically in Figure 1 of the revised manuscript.
Response to Reviewer #3
Comment 1: The most major concern with this paper is that this paper added little new findings. The paper published in 2011 by Sakuma et al. already showed the detailed epidemiology of potentially inappropriate medication use defined by Beers Criteria in elderly inpatients in Japanese acute care hospitals, which was a prospective cohort study including 2155 elderly inpatients. Response: Thank you for your comments. I am aware of the Japanese study conducted by Sakuma et al (Pharmacoepidemiol Drug Saf 2011; 20(4):386-92) . I think that this study is the first to investigate the epidemiology of PIM use, as defined by the Beers criteria, in elderly inpatients in Japanese acute care hospitals. However, the study conducted by Sakuma et al did not target medications at admission and at discharge but medications that prescribed during hospitalization. Therefore, the design of the study conducted by Sakuma et al differs from that of past studies conducted in countries outside Japan to investigate the temporal change in PIM prevalence from admission to discharge in hospitalized elderly patients ( think that the present study is the first to determine the prevalence of PIM use at admission and discharge and evaluate the temporal change in PIM use from admission to discharge in Japan. Given that hospitalization due to medical illness offers a good opportunity to review medications and discontinue inappropriate medications (BMJ 2016; 353: i2893) , it is important to determine the temporal change in PIM prevalence from admission to discharge. Nonetheless, the study by Sakuma el al provides important research regarding the epidemiology of PIM use in hospitalized elderly patients in Japan. I have referred to this study in the Discussion section of the revised manuscript (Page 13-14, Line 230-233).
Comment 2: Though the continuous variables are all presented as means and SD, some variables may be appropriate to be presented as medians with interquartile range. Generally, the distribution of the number of medications tends to be skewed. Response: Thank you for your comment. According to your suggestions, age, Charlson Comorbidity Index, number of medications, and duration of hospital stay were presented as medians with interquartile ranges in the revised manuscript.
Comment 3: In discussion, the author did not show any application or clinical implications of findings from this study. Therefore, I can not understand the value or impact of findings from this study on healthcare of Japan or worldwide. In addition, the author did not mention about the reason of PIMs reduction. More discussion about the interpretation of the PIMs reduction could be interesting. Response: Thank you for your comment. According to your suggestions, the clinical implications of findings of this study have been added to the Discussion section (Page 17, Line 293-300). I think that the most important implication is that the prevalence of PIM use in hospitalized elderly patients was still high at discharge even though hospitalization due to medical illness provides a good opportunity to review medications and discontinue inappropriate one (BMJ 2016; 353: i2893) . Additionally, the reason for the PIM reduction observed in the present study has also been discussed in the revised manuscript. I think that the efforts of internal medicine physicians at my hospital to avoid and reduce PIM and polypharmacy for elderly patients might have contributed the reduction of PIMs from admission to discharge (BMC Geriatrics 2017; 17:288) , although this is not a scientific explanation. This information has been added to the Discussion section of the revised manuscript (Page 15, Line 250-255). Comment 5: May need some language corrections before being published. Response: I apologize for this point. The revised manuscript has also been edited by a native English speaker at American Journal Experts. I apologize if I did not respond to your suggestion appropriately.
Response to Reviewer #4
Comment 1: Kindly apply multivariate logistic regression, binary logistic regression to predict the impact of parameters predictor variables (like age, gender, length of stay, number of medication presence of co-morbities impact of these parameters) on potential inappropriate medications (PIM). Response: Thank you for your comment. According to your suggestion, a multivariate analysis using binary logistic regression to examine the association between the use of any PIMs at discharge and selected variables (age, gender, length of stay, Charlson Comorbidity Index, and number of medications at admission) was conducted. The results of this analysis are shown in Table 3 and the Results section of the revised manuscript (Page 12-13, Line 211-215).
Comment 2: You have applied two of five Beers criteria so kindly provide which two criteria you have used and also mention the reason that why haven't you used the other three criteria. Response: Thank you for your comment. The Beers criteria were updated in 1997, 2003, 2012, and 2015 . Of the five parts of the 2015 Beers criteria, the two parts that were used in the present study have existed since the 1997 Beers criteria. However, two other parts ("drugs for which dose adjustment is required based on kidney function" and "drug-drug interactions") have been newly added to the 2015 AGS Beers criteria. Neither of these new additions is intended to be comprehensive (J Am Geriatr Soc 2015; 63:2227 -2246 . The remaining part is related to "PIM to be used with caution" rather than "PIM". Therefore, the other three parts of the 2015 Beers criteria were not used. This information has been added in the Method section of the revised manuscript (Page 8, Line 137-138).
Comment 3: Kindly provide the statistical significant p-value for table 3. Response: Thank you for your comment. According to your suggestion, the statistically significant pvalue has been added to Table 4 of the revised manuscript. 
GENERAL COMMENTS
After thoroughly reviewing, the content of this paper seems to be appropriate and should be considered for publishing.
REVIEWER
Mio Sakuma, MD, PhD, MPH Hyogo College of Meidicine, Japan REVIEW RETURNED 14-Mar-2018
GENERAL COMMENTS
Thank you for the revised manuscript and it has been improved. A few additional comments on the revised manuscript below:
The authors reported the result of multivariate analysis. The purpose of this analysis is not clear to me. Was it conducted to examine the risk factors of the use of PIMs at discharge (as mentioned the result section in the paper) ? Looking for the variables which predict the use of any PIMs at discharge (as mentioned at the title of Table 3 ) ? Depend on the purpose, the strategy of building the model should be completely different. Please make that point clear and consistent in the paper. Also, including both "men" and "women" in the same model is considered inappropriate.
Please consider adding the table that lists which PIMs (subcategories of drugs) were discontinued during hospitalization. The author showed the significant reduction of PIMs use between admission and discharge as main outcome, and mentioned in discussion section that the physicians at the hospital in this paper make efforts to avoid PIMs and polypharmacy during hospitalization, then, it would be more informative and interesting to see which PIMs could be discontinued during hospitalization displayed. Response to Reviewer #4 Comment: After thoroughly reviewing, the content of this paper seems to be appropriate and should be considered for publishing.
VERSION 2 -AUTHOR RESPONSE
Response: Thank you very much for the helpful comments.
Response to Reviewer #3 Comment: The authors reported the result of multivariate analysis. The purpose of this analysis is not clear to me. Was it conducted to examine the risk factors of the use of PIMs at discharge (as mentioned the result section in the paper) ? Looking for the variables which predict the use of any PIMs at discharge (as mentioned at the title of Table 3 ) ? Depend on the purpose, the strategy of building the model should be completely different. Please make that point clear and consistent in the paper. Also, including both "men" and "women" in the same model is considered inappropriate.
